Aurobindo Pharma News Today

Press Release Hyderabad, India, March 19, 2024 Aurobindo Pharma receives USFDA Approval for Mometasone Furoate Monohydrate Nasal Spray ...

Check the brokerage calls and comments on the stocks in action. Today we cover Aurobindo Pharma, Nazara Tech, LIC among others following their Q4 results.

Prabhudas Lilladher recommended accumulate rating on Aurobindo Pharma with a target price of Rs 1300 in its research report dated May 28, 2024.

LIC, NMDC, Nalco, Sumitomo Chemicals, Elgi Equipments, NMDC Steel, Natco Pharma, GMDC, TVS Supply Chain Solutions, MSTC and more will announce their quarterly results today.

GAIL (India) Ltd. opened its first 10 MW Green Hydrogen Plant as part of the National Green Hydrogen Mission at Vijaipur, Madhya Pradesh.

Aurobindo Pharma | The company had reported 80 percent rise in consolidated net profit to Rs 909 crore in the Jan-March quarter of FY24 from Rs 508 crore in the same period a year ago.

Stocks to watch on Monday, May 27, 2024: Indian equities may have a steady start to the week on Monday, as...

The NSE Nifty fell 10.60 points or 0.05 per cent to close at 22,957.10. Sector-wise it was a mixed bag with buying seen in Oil & Gas, Banking, and Financials

Nifty closed the week with a 2.2% increase despite notable ups and downs, as seen in the India VIX reaching a 52-week peak with almost a 10% rise over four sessions. As trading resumes next Monday, numerous significant local and international events scheduled throughout the week are anticipated to influence market dynamics.

More than 300 companies will release their quarterly earnings on May 27 including Life Insurance Corporation of India, Astrazeneca Pharma, Borosil Renewables, Flair Writing Industries, Jubilant Industries, Natco Pharma, and NALCO.